PharmaResources (Shanghai) Co. Ltd. A Cash Flow Reinvestment Rate
PharmaResources (Shanghai) Co. Ltd. A cash flow reinvestment rate. PharmaResources (Shanghai) Co. Ltd. A (301230) has a Cash Flow Reinvestment Rate of 0.32x as of December 2025, reinvesting CN¥43.51 Million (capex CN¥43.32 Million plus investments CN¥-194.62K) from operating cash flow of CN¥135.51 Million. Explore how well can PharmaResources (Shanghai) Co. Ltd. A service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of PharmaResources (Shanghai) Co. Ltd. A (2020–2025)
Cash flow reinvestment rate of PharmaResources (Shanghai) Co. Ltd. A from 2020 to 2025. Historical reinvestment intensity for PharmaResources (Shanghai) Co. Ltd. A across 6 annual periods. Explore PharmaResources (Shanghai) Co. Ltd. A capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
PharmaResources (Shanghai) Co. Ltd. A Cash Flow Reinvestment Rate by Year (2020–2025)
PharmaResources (Shanghai) Co. Ltd. A cash flow reinvestment rate by year from 2020 to 2025. Year-by-year capital reinvestment analysis for PharmaResources (Shanghai) Co. Ltd. A. For the full cash flow conversion analysis, see PharmaResources (Shanghai) Co. Ltd. A cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.32x | CN¥43.51 Million | CN¥135.51 Million | CN¥43.32 Million | ▼ -85.1% |
| 2024 | 2.15x | CN¥173.84 Million | CN¥80.86 Million | CN¥109.40 Million | ▼ -94.6% |
| 2023 | 39.82x | CN¥830.55 Million | CN¥20.86 Million | CN¥248.27 Million | ▲ +1445.8% |
| 2022 | 2.58x | CN¥255.77 Million | CN¥99.29 Million | CN¥123.97 Million | ▲ +48.5% |
| 2021 | 1.73x | CN¥182.37 Million | CN¥105.12 Million | CN¥92.12 Million | ▲ +83.6% |
| 2020 | 0.94x | CN¥51.46 Million | CN¥54.45 Million | CN¥33.51 Million | — |